This inventor holds 1 USPTO granted patent. Top assignee: Oravax, Inc.. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Rainier Haas: Innovator in Vaccine Development
Introduction
Rainier Haas is a notable inventor based in Tübingen, Switzerland. He has made significant contributions to the field of immunology, particularly in the development of vaccines. His innovative work focuses on addressing Helicobacter infections, which are known to cause various gastrointestinal diseases.
Latest Patents
Rainier Haas holds a patent for a urease-based vaccine and treatment for Helicobacter infection. This patent outlines a method of eliciting a protective immune response in a mammalian host against Helicobacter infection. The treatment involves administering an immunogenically effective amount of Helicobacter urease or urease subunits as an antigen. Additionally, the patent provides vaccine compositions aimed at enhancing the immune response.
Career Highlights
Haas is currently associated with Oravax, Inc., where he continues to advance his research in vaccine development. His work is pivotal in creating effective treatments for Helicobacter infections, which can have serious health implications.
Collaborations
Rainier Haas has collaborated with esteemed colleagues, including Irène Corthésy-Theulaz and André Blum. These partnerships have contributed to the advancement of his research and the development of innovative solutions in the field of immunology.
Conclusion
Rainier Haas is a prominent figure in vaccine innovation, with a focus on combating Helicobacter infections. His contributions through patents and collaborations highlight his commitment to improving public health through scientific advancements.